POSTPRANDIAL HYPOGLYCAEMIA

This adverse event was reported 187 times

These drugs are most commonly taken by patients reporting POSTPRANDIAL HYPOGLYCAEMIA:

# Drug Count
0 METFORMIN 34
1 METFORMIN ER 500 MG 28
2 METFORMIN ER 750 MG 28
3 INSULIN GLARGINE 16
4 SIMVASTATIN 13
5 TELMISARTAN 13
6 INSULIN LISPRO 12
7 TIRZEPATIDE 11
8 GLIMEPIRIDE 10
9 INSULIN GLARGINE-YFGN 10
See all common drugs associated with POSTPRANDIAL HYPOGLYCAEMIA

POSTPRANDIAL HYPOGLYCAEMIA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 MECASERMIN 3 0.0037
1 CABERGOLINE 8 0.0016
2 TEPLIZUMAB-MZWV 1 0.0014
3 SODIUM PICOSULFATE, MAGNESIUM OXIDE, AND ANHYDROUS CITRIC ACID 1 0.0014
4 TERCONAZOLE 1 0.0012
5 MIGLITOL 1 0.0010
6 NORETHINDRONE AND ETHINYL ESTRADIOL 1 0.0009
7 METHYLCELLULOSE 2 0.0009
8 ACARBOSE 3 0.0008
9 INSULIN ASPART INJECTION 2 0.0007
See all drugs enriched for association with POSTPRANDIAL HYPOGLYCAEMIA

POSTPRANDIAL HYPOGLYCAEMIA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Ergot Derivative [EPC] 8 0.0016
1 CD3-directed Antibody [EPC] 1 0.0014
2 alpha-Glucosidase Inhibitor [EPC] 4 0.0008
3 Dopamine and Norepinephrine Reuptake Inhibitor [EPC] 2 0.0005
4 Somatostatin Analog [EPC] 2 0.0003
5 Recombinant Human Growth Hormone [EPC] 6 0.0003
6 Provitamin D2 Compound [EPC] 8 0.0003
7 Anti-coagulant [EPC] 1 0.0003
8 Antiparasitic [EPC] 1 0.0002
9 Androgen [EPC] 6 0.0002
See all drug classes enriched for association with POSTPRANDIAL HYPOGLYCAEMIA